The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: Preliminary data


BAŞYİĞİT İ. , YILDIZ F. F. , ÖZKARA S. , YILDIRIM E., BOYACI H. , ILGAZLI A. H.

ANNALS OF PHARMACOTHERAPY, cilt.38, ss.1400-1405, 2004 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 38 Konu: 9
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1345/aph.1d634
  • Dergi Adı: ANNALS OF PHARMACOTHERAPY
  • Sayfa Sayıları: ss.1400-1405

Özet

BACKGROUND: Clarithromycin is an antimicrobial agent that can be used for treatment of chronic obstructive pulmonary disease (COPD) exacerbations with bronchodilator therapy. However, it has also been shown that clarithromycin has antiinflammatory effects by the inhibition of cytokine production.